Click for best price
Omalizumab Biosimilars Market Size, Share 2022
Omalizumab is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Unlike an ordinary anti-IgE antibody, it does not bind to IgE that is already bound by the high affinity IgE receptor (Fc?RI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.
This report contains market size and forecasts of Omalizumab Biosimilars in global, including the following market information:
Global Omalizumab Biosimilars Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Omalizumab Biosimilars Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Omalizumab Biosimilars companies in 2021 (%)
The global Omalizumab Biosimilars market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
150 mg/mL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Omalizumab Biosimilars include Roche, Novartis, Glenmark Pharmaceuticals, Selexis, Generium, CuraTeQ, Celltrion Healthcare, Alvotech and BiosanaPharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Omalizumab Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Omalizumab Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Omalizumab Biosimilars Market Segment Percentages, by Type, 2021 (%)
150 mg/mL
75 mg/0.5 mL
Global Omalizumab Biosimilars Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Omalizumab Biosimilars Market Segment Percentages, by Application, 2021 (%)
Persistent Asthma
Nasal Polyps
Chronic Idiopathic Urticaria
Global Omalizumab Biosimilars Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Omalizumab Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Omalizumab Biosimilars revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Omalizumab Biosimilars revenues share in global market, 2021 (%)
Key companies Omalizumab Biosimilars sales in global market, 2017-2022 (Estimated), (Units)
Key companies Omalizumab Biosimilars sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Glenmark Pharmaceuticals
Selexis
Generium
CuraTeQ
Celltrion Healthcare
Alvotech
BiosanaPharma
Mabpharm
CSPC Pharmaceutical Group
Biomabs
HisunPharm
Grand Pharm
| Report Attributes |
Report Details |
| Report Title |
Omalizumab Biosimilars Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Omalizumab Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Omalizumab Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Omalizumab Biosimilars Overall Market Size
2.1 Global Omalizumab Biosimilars Market Size: 2021 VS 2028
2.2 Global Omalizumab Biosimilars Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Omalizumab Biosimilars Sales: 2017-2028
3 Company Landscape
3.1 Top Omalizumab Biosimilars Players in Global Market
3.2 Top Global Omalizumab Biosimilars Companies Ranked by Revenue
3.3 Global Omalizumab Biosimilars Revenue by Companies
3.4 Global Omalizumab Biosimilars Sales by Companies
3.5 Global Omalizumab Biosimilars Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Omalizumab Biosimilars Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Omalizumab Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Omalizumab Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Omalizumab Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Omalizumab Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Omalizumab Biosimilars Market Size Markets, 2021 & 2028
4.1.2 150 mg/mL
4.1.3 75 mg/0.5 mL
4.2 By Type - Global Omalizumab Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Omalizumab Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global Omalizumab Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global Omalizumab Biosimilars Revenue Market Share, 2017-2028
4.3 By Type - Global Omalizumab Biosimilars Sales & Forecasts
4.3.1 By Type - Global Omalizumab Biosimilars Sales, 2017-2022
4.3.2 By Type - Global Omalizumab Biosimilars Sales, 2023-2028
4.3.3 By Type - Global Omalizumab Biosimilars Sales Market Share, 2017-2028
4.4 By Type - Global Omalizumab Biosimilars Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Omalizumab Biosimilars Market Size, 2021 & 2028
5.1.2 Persistent Asthma
5.1.3 Nasal Polyps
5.1.4 Chronic Idiopathic Urticaria
5.2 By Application - Global Omalizumab Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Omalizumab Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global Omalizumab Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global Omalizumab Biosimilars Revenue Market Share, 2017-2028
5.3 By Application - Global Omalizumab Biosimilars Sales & Forecasts
5.3.1 By Application - Global Omalizumab Biosimilars Sales, 2017-2022
5.3.2 By Application - Global Omalizumab Biosimilars Sales, 2023-2028
5.3.3 By Application - Global Omalizumab Biosimilars Sales Market Share, 2017-2028
5.4 By Application - Global Omalizumab Biosimilars Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Omalizumab Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global Omalizumab Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Omalizumab Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global Omalizumab Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global Omalizumab Biosimilars Revenue Market Share, 2017-2028
6.3 By Region - Global Omalizumab Biosimilars Sales & Forecasts
6.3.1 By Region - Global Omalizumab Biosimilars Sales, 2017-2022
6.3.2 By Region - Global Omalizumab Biosimilars Sales, 2023-2028
6.3.3 By Region - Global Omalizumab Biosimilars Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Omalizumab Biosimilars Revenue, 2017-2028
6.4.2 By Country - North America Omalizumab Biosimilars Sales, 2017-2028
6.4.3 US Omalizumab Biosimilars Market Size, 2017-2028
6.4.4 Canada Omalizumab Biosimilars Market Size, 2017-2028
6.4.5 Mexico Omalizumab Biosimilars Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Omalizumab Biosimilars Revenue, 2017-2028
6.5.2 By Country - Europe Omalizumab Biosimilars Sales, 2017-2028
6.5.3 Germany Omalizumab Biosimilars Market Size, 2017-2028
6.5.4 France Omalizumab Biosimilars Market Size, 2017-2028
6.5.5 U.K. Omalizumab Biosimilars Market Size, 2017-2028
6.5.6 Italy Omalizumab Biosimilars Market Size, 2017-2028
6.5.7 Russia Omalizumab Biosimilars Market Size, 2017-2028
6.5.8 Nordic Countries Omalizumab Biosimilars Market Size, 2017-2028
6.5.9 Benelux Omalizumab Biosimilars Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Omalizumab Biosimilars Revenue, 2017-2028
6.6.2 By Region - Asia Omalizumab Biosimilars Sales, 2017-2028
6.6.3 China Omalizumab Biosimilars Market Size, 2017-2028
6.6.4 Japan Omalizumab Biosimilars Market Size, 2017-2028
6.6.5 South Korea Omalizumab Biosimilars Market Size, 2017-2028
6.6.6 Southeast Asia Omalizumab Biosimilars Market Size, 2017-2028
6.6.7 India Omalizumab Biosimilars Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Omalizumab Biosimilars Revenue, 2017-2028
6.7.2 By Country - South America Omalizumab Biosimilars Sales, 2017-2028
6.7.3 Brazil Omalizumab Biosimilars Market Size, 2017-2028
6.7.4 Argentina Omalizumab Biosimilars Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Omalizumab Biosimilars Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Omalizumab Biosimilars Sales, 2017-2028
6.8.3 Turkey Omalizumab Biosimilars Market Size, 2017-2028
6.8.4 Israel Omalizumab Biosimilars Market Size, 2017-2028
6.8.5 Saudi Arabia Omalizumab Biosimilars Market Size, 2017-2028
6.8.6 UAE Omalizumab Biosimilars Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Omalizumab Biosimilars Major Product Offerings
7.1.4 Roche Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.1.5 Roche Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Omalizumab Biosimilars Major Product Offerings
7.2.4 Novartis Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 Glenmark Pharmaceuticals
7.3.1 Glenmark Pharmaceuticals Corporate Summary
7.3.2 Glenmark Pharmaceuticals Business Overview
7.3.3 Glenmark Pharmaceuticals Omalizumab Biosimilars Major Product Offerings
7.3.4 Glenmark Pharmaceuticals Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.3.5 Glenmark Pharmaceuticals Key News
7.4 Selexis
7.4.1 Selexis Corporate Summary
7.4.2 Selexis Business Overview
7.4.3 Selexis Omalizumab Biosimilars Major Product Offerings
7.4.4 Selexis Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.4.5 Selexis Key News
7.5 Generium
7.5.1 Generium Corporate Summary
7.5.2 Generium Business Overview
7.5.3 Generium Omalizumab Biosimilars Major Product Offerings
7.5.4 Generium Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.5.5 Generium Key News
7.6 CuraTeQ
7.6.1 CuraTeQ Corporate Summary
7.6.2 CuraTeQ Business Overview
7.6.3 CuraTeQ Omalizumab Biosimilars Major Product Offerings
7.6.4 CuraTeQ Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.6.5 CuraTeQ Key News
7.7 Celltrion Healthcare
7.7.1 Celltrion Healthcare Corporate Summary
7.7.2 Celltrion Healthcare Business Overview
7.7.3 Celltrion Healthcare Omalizumab Biosimilars Major Product Offerings
7.7.4 Celltrion Healthcare Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.7.5 Celltrion Healthcare Key News
7.8 Alvotech
7.8.1 Alvotech Corporate Summary
7.8.2 Alvotech Business Overview
7.8.3 Alvotech Omalizumab Biosimilars Major Product Offerings
7.8.4 Alvotech Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.8.5 Alvotech Key News
7.9 BiosanaPharma
7.9.1 BiosanaPharma Corporate Summary
7.9.2 BiosanaPharma Business Overview
7.9.3 BiosanaPharma Omalizumab Biosimilars Major Product Offerings
7.9.4 BiosanaPharma Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.9.5 BiosanaPharma Key News
7.10 Mabpharm
7.10.1 Mabpharm Corporate Summary
7.10.2 Mabpharm Business Overview
7.10.3 Mabpharm Omalizumab Biosimilars Major Product Offerings
7.10.4 Mabpharm Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.10.5 Mabpharm Key News
7.11 CSPC Pharmaceutical Group
7.11.1 CSPC Pharmaceutical Group Corporate Summary
7.11.2 CSPC Pharmaceutical Group Omalizumab Biosimilars Business Overview
7.11.3 CSPC Pharmaceutical Group Omalizumab Biosimilars Major Product Offerings
7.11.4 CSPC Pharmaceutical Group Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.11.5 CSPC Pharmaceutical Group Key News
7.12 Biomabs
7.12.1 Biomabs Corporate Summary
7.12.2 Biomabs Omalizumab Biosimilars Business Overview
7.12.3 Biomabs Omalizumab Biosimilars Major Product Offerings
7.12.4 Biomabs Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.12.5 Biomabs Key News
7.13 HisunPharm
7.13.1 HisunPharm Corporate Summary
7.13.2 HisunPharm Omalizumab Biosimilars Business Overview
7.13.3 HisunPharm Omalizumab Biosimilars Major Product Offerings
7.13.4 HisunPharm Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.13.5 HisunPharm Key News
7.14 Grand Pharm
7.14.1 Grand Pharm Corporate Summary
7.14.2 Grand Pharm Business Overview
7.14.3 Grand Pharm Omalizumab Biosimilars Major Product Offerings
7.14.4 Grand Pharm Omalizumab Biosimilars Sales and Revenue in Global (2017-2022)
7.14.5 Grand Pharm Key News
8 Global Omalizumab Biosimilars Production Capacity, Analysis
8.1 Global Omalizumab Biosimilars Production Capacity, 2017-2028
8.2 Omalizumab Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Omalizumab Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Omalizumab Biosimilars Supply Chain Analysis
10.1 Omalizumab Biosimilars Industry Value Chain
10.2 Omalizumab Biosimilars Upstream Market
10.3 Omalizumab Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Omalizumab Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Omalizumab Biosimilars in Global Market
Table 2. Top Omalizumab Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Omalizumab Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Omalizumab Biosimilars Revenue Share by Companies, 2017-2022
Table 5. Global Omalizumab Biosimilars Sales by Companies, (Units), 2017-2022
Table 6. Global Omalizumab Biosimilars Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Omalizumab Biosimilars Price (2017-2022) & (K USD/Unit)
Table 8. Global Manufacturers Omalizumab Biosimilars Product Type
Table 9. List of Global Tier 1 Omalizumab Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Omalizumab Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Omalizumab Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Omalizumab Biosimilars Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Omalizumab Biosimilars Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Omalizumab Biosimilars Sales (Units), 2017-2022
Table 15. By Type - Global Omalizumab Biosimilars Sales (Units), 2023-2028
Table 16. By Application ? Global Omalizumab Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Omalizumab Biosimilars Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Omalizumab Biosimilars Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Omalizumab Biosimilars Sales (Units), 2017-2022
Table 20. By Application - Global Omalizumab Biosimilars Sales (Units), 2023-2028
Table 21. By Region ? Global Omalizumab Biosimilars Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Omalizumab Biosimilars Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Omalizumab Biosimilars Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Omalizumab Biosimilars Sales (Units), 2017-2022
Table 25. By Region - Global Omalizumab Biosimilars Sales (Units), 2023-2028
Table 26. By Country - North America Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Omalizumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Omalizumab Biosimilars Sales, (Units), 2017-2022
Table 29. By Country - North America Omalizumab Biosimilars Sales, (Units), 2023-2028
Table 30. By Country - Europe Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Omalizumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Omalizumab Biosimilars Sales, (Units), 2017-2022
Table 33. By Country - Europe Omalizumab Biosimilars Sales, (Units), 2023-2028
Table 34. By Region - Asia Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Omalizumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Omalizumab Biosimilars Sales, (Units), 2017-2022
Table 37. By Region - Asia Omalizumab Biosimilars Sales, (Units), 2023-2028
Table 38. By Country - South America Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Omalizumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Omalizumab Biosimilars Sales, (Units), 2017-2022
Table 41. By Country - South America Omalizumab Biosimilars Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Omalizumab Biosimilars Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Omalizumab Biosimilars Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Omalizumab Biosimilars Sales, (Units), 2023-2028
Table 46. Roche Corporate Summary
Table 47. Roche Omalizumab Biosimilars Product Offerings
Table 48. Roche Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis Omalizumab Biosimilars Product Offerings
Table 51. Novartis Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 52. Glenmark Pharmaceuticals Corporate Summary
Table 53. Glenmark Pharmaceuticals Omalizumab Biosimilars Product Offerings
Table 54. Glenmark Pharmaceuticals Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 55. Selexis Corporate Summary
Table 56. Selexis Omalizumab Biosimilars Product Offerings
Table 57. Selexis Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 58. Generium Corporate Summary
Table 59. Generium Omalizumab Biosimilars Product Offerings
Table 60. Generium Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 61. CuraTeQ Corporate Summary
Table 62. CuraTeQ Omalizumab Biosimilars Product Offerings
Table 63. CuraTeQ Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 64. Celltrion Healthcare Corporate Summary
Table 65. Celltrion Healthcare Omalizumab Biosimilars Product Offerings
Table 66. Celltrion Healthcare Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 67. Alvotech Corporate Summary
Table 68. Alvotech Omalizumab Biosimilars Product Offerings
Table 69. Alvotech Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 70. BiosanaPharma Corporate Summary
Table 71. BiosanaPharma Omalizumab Biosimilars Product Offerings
Table 72. BiosanaPharma Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 73. Mabpharm Corporate Summary
Table 74. Mabpharm Omalizumab Biosimilars Product Offerings
Table 75. Mabpharm Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 76. CSPC Pharmaceutical Group Corporate Summary
Table 77. CSPC Pharmaceutical Group Omalizumab Biosimilars Product Offerings
Table 78. CSPC Pharmaceutical Group Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 79. Biomabs Corporate Summary
Table 80. Biomabs Omalizumab Biosimilars Product Offerings
Table 81. Biomabs Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 82. HisunPharm Corporate Summary
Table 83. HisunPharm Omalizumab Biosimilars Product Offerings
Table 84. HisunPharm Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 85. Grand Pharm Corporate Summary
Table 86. Grand Pharm Omalizumab Biosimilars Product Offerings
Table 87. Grand Pharm Omalizumab Biosimilars Sales (Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
Table 88. Omalizumab Biosimilars Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 89. Global Omalizumab Biosimilars Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Omalizumab Biosimilars Production by Region, 2017-2022 (Units)
Table 91. Global Omalizumab Biosimilars Production by Region, 2023-2028 (Units)
Table 92. Omalizumab Biosimilars Market Opportunities & Trends in Global Market
Table 93. Omalizumab Biosimilars Market Drivers in Global Market
Table 94. Omalizumab Biosimilars Market Restraints in Global Market
Table 95. Omalizumab Biosimilars Raw Materials
Table 96. Omalizumab Biosimilars Raw Materials Suppliers in Global Market
Table 97. Typical Omalizumab Biosimilars Downstream
Table 98. Omalizumab Biosimilars Downstream Clients in Global Market
Table 99. Omalizumab Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Omalizumab Biosimilars Segment by Type
Figure 2. Omalizumab Biosimilars Segment by Application
Figure 3. Global Omalizumab Biosimilars Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Omalizumab Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Omalizumab Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. Omalizumab Biosimilars Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Omalizumab Biosimilars Revenue in 2021
Figure 9. By Type - Global Omalizumab Biosimilars Sales Market Share, 2017-2028
Figure 10. By Type - Global Omalizumab Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Type - Global Omalizumab Biosimilars Price (K USD/Unit), 2017-2028
Figure 12. By Application - Global Omalizumab Biosimilars Sales Market Share, 2017-2028
Figure 13. By Application - Global Omalizumab Biosimilars Revenue Market Share, 2017-2028
Figure 14. By Application - Global Omalizumab Biosimilars Price (K USD/Unit), 2017-2028
Figure 15. By Region - Global Omalizumab Biosimilars Sales Market Share, 2017-2028
Figure 16. By Region - Global Omalizumab Biosimilars Revenue Market Share, 2017-2028
Figure 17. By Country - North America Omalizumab Biosimilars Revenue Market Share, 2017-2028
Figure 18. By Country - North America Omalizumab Biosimilars Sales Market Share, 2017-2028
Figure 19. US Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Omalizumab Biosimilars Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Omalizumab Biosimilars Sales Market Share, 2017-2028
Figure 24. Germany Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. France Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Omalizumab Biosimilars Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Omalizumab Biosimilars Sales Market Share, 2017-2028
Figure 33. China Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. India Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Omalizumab Biosimilars Revenue Market Share, 2017-2028
Figure 39. By Country - South America Omalizumab Biosimilars Sales Market Share, 2017-2028
Figure 40. Brazil Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Omalizumab Biosimilars Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Omalizumab Biosimilars Sales Market Share, 2017-2028
Figure 44. Turkey Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Omalizumab Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 48. Global Omalizumab Biosimilars Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Omalizumab Biosimilars by Region, 2021 VS 2028
Figure 50. Omalizumab Biosimilars Industry Value Chain
Figure 51. Marketing Channels
